Ex parte BONFILS et al. - Page 18




               Appeal No. 2001-2138                                                                                                
               Application No. 08/403,276                                                                                          


               evidence supported a prima facie case of obviousness.  The broad proposition is thus                                

               mere dicta, as it was unnecessary for the court’s decision.                                                         

                       In In re Anthony, 414 F.2d 1383, 162 USPQ 594 (CCPA 1969), Anthony conceded                                 

               a prima facie case of obviousness of the claims to d-and l-enantiomers over a prior art                             

               teaching of the racemate.  Id. at 1386, 162 USPQ at 596.  Thus, the issue was not in                                

               controversy, and the court’s statements, which are limited to reporting the course of                               

               proceedings below, are dicta.                                                                                       

                       The examiner has not directed our attention to any evidence in the record that the                          
               ordinary steroid chemist would have expected that the enantiomers of the RUS1                                       
               compounds would have affected spermazoid activity, as disclosed by Appellants, or that                              
               the enantiomers would have any particular common pharmacological properties.  Thus, the                             
               examiner has not shown that RUS1 provides any suggestion to make or use the claimed                                 
               enantiomers.  Accordingly, we reverse this rejection.                                                               
                       Appellants appear to urge that the failure of RUS1 to teach any utility for the claimed                     
               compounds, and the known unpredictable nature of the changes in activity, toxicity, and                             
               utility due to changes in chirality, require reversal of the examiner’s rejection.  (Brief at 4.)                   
               To the extent that Appellants intend to argue that the examiner has not established any                             
               basis for concluding that one of ordinary skill in the art would have had a reasonable                              
               expectation that the claimed compounds would have similar biological properties as the                              

                                                              - 18 -                                                               





Page:  Previous  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  Next 

Last modified: November 3, 2007